Back
Ultragenyx Pharmaceutical Stock Predictions
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
7 Day Trial
ALL ACCESS PASS
$
7
Ultragenyx Pharmaceutical Stock Forecast
- Over the next 52 weeks, Ultragenyx Pharmaceutical has on average historically risen by 5.3% based on the past 10 years of stock performance.
- Ultragenyx Pharmaceutical has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Ultragenyx Pharmaceutical Stock Undervalued?
The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal. - RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ultragenyx Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Ultragenyx Pharmaceutical has on average historically risen by 5.3% based on the past 10 years of stock performance.
Ultragenyx Pharmaceutical Stock Rating
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical overpriced?
- Ultragenyx Pharmaceutical has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Ultragenyx Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ultragenyx.com
52-Week Data
52-Week High:
54.56
52-Week Low:
31.52
Prediction Charts
Market Cap:
3.59B
Price in USD:
39.60
Volume:
766.32K
Beta:
1.09
Technical Analysis
SMA50:
41.94
SMA100:
44.93
SMA200:
42.46
52-Wk Change:
-24.07%
Stock Predictions
-
Is Ultragenyx Pharmaceutical stock public?
Yes, Ultragenyx Pharmaceutical is a publicly traded company. -
What is the Ultragenyx Pharmaceutical stock quote today?
The Ultragenyx Pharmaceutical stock price is 39.60 USD today. -
How to buy Ultragenyx Pharmaceutical stock online?
You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-3 | 40.58 | 41.13 | 41.48 | 39.46 |
Jun-4 | 41.06 | 40.92 | 41.90 | 40.08 |
Jun-5 | 41.34 | 41.45 | 42.01 | 40.60 |
Jun-6 | 43.78 | 41.77 | 44.00 | 41.41 |
Jun-7 | 41.24 | 41.40 | 41.76 | 40.98 |
Jun-10 | 41.10 | 41.99 | 42.00 | 40.75 |
Jun-11 | 41.47 | 41.40 | 41.97 | 40.55 |
Jun-12 | 42.60 | 44.64 | 45.59 | 41.86 |
Jun-13 | 42.94 | 43.15 | 44.45 | 42.27 |
Jun-14 | 40.93 | 39.05 | 41.00 | 38.16 |
Jun-17 | 39.29 | 39.80 | 40.00 | 38.51 |
Jun-18 | 39.69 | 37.42 | 39.69 | 37.02 |
Jun-20 | 37.27 | 38.02 | 38.66 | 37.27 |
Jun-21 | 38.36 | 39.60 | 39.64 | 38.24 |
Ultragenyx Pharmaceutical Earnings
Ultragenyx Pharmaceutical Earnings Report: Per Share Ultragenyx Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ultragenyx Pharmaceutical Forecast Revenue Growth
Ultragenyx Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Ultragenyx Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.